ProShare Advisors’s GALENA BIOPHARMA INC COM RXII Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | – | Sell |
-20,894
| Closed | -$7K | – | 1781 |
|
2016
Q3 | $7K | Sell |
20,894
-1,536
| -7% | -$515 | ﹤0.01% | 1459 |
|
2016
Q2 | $10K | Buy |
22,430
+191
| +0.9% | +$85 | ﹤0.01% | 1581 |
|
2016
Q1 | $30K | Sell |
22,239
-1,302
| -6% | -$1.76K | ﹤0.01% | 1566 |
|
2015
Q4 | $35K | Buy |
23,541
+8,126
| +53% | +$12.1K | ﹤0.01% | 1688 |
|
2015
Q3 | $24K | Sell |
15,415
-4,993
| -24% | -$7.77K | ﹤0.01% | 1427 |
|
2015
Q2 | $35K | Sell |
20,408
-2,395
| -11% | -$4.11K | ﹤0.01% | 1626 |
|
2015
Q1 | $32K | Sell |
22,803
-2,540
| -10% | -$3.56K | ﹤0.01% | 1893 |
|
2014
Q4 | $38K | Sell |
25,343
-21,545
| -46% | -$32.3K | ﹤0.01% | 1933 |
|
2014
Q3 | $97K | Sell |
46,888
-10,629
| -18% | -$22K | ﹤0.01% | 2173 |
|
2014
Q2 | $176K | Sell |
57,517
-46,024
| -44% | -$141K | ﹤0.01% | 2223 |
|
2014
Q1 | $259K | Buy |
+103,541
| New | +$259K | ﹤0.01% | 2346 |
|
2013
Q4 | – | Sell |
-52,729
| Closed | -$120K | – | 2482 |
|
2013
Q3 | $120K | Buy |
+52,729
| New | +$120K | ﹤0.01% | 2368 |
|